These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 27003600)

  • 21. Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.
    El Hadi H; Di Vincenzo A; Vettor R; Rossato M
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD).
    Chociej AB; Wasilewska N; Flisiak-Jackiewicz M; Lebensztejn D
    Curr Pediatr Rev; 2020; 16(4):294-297. PubMed ID: 33038914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community.
    Rajindrajith S; Pathmeswaran A; Jayasinghe C; Kottahachchi D; Kasturiratne A; de Silva ST; Niriella MA; Dassanayake AS; de Silva AP; de Silva HJ
    BMC Gastroenterol; 2017 Nov; 17(1):135. PubMed ID: 29187144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease and the heart in children and adolescents.
    Pacifico L; Chiesa C; Anania C; De Merulis A; Osborn JF; Romaggioli S; Gaudio E
    World J Gastroenterol; 2014 Jul; 20(27):9055-71. PubMed ID: 25083079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease.
    Tzifi F; Fretzayas A; Chrousos G; Kanaka-Gantenbein C
    Hormones (Athens); 2019 Sep; 18(3):255-265. PubMed ID: 31140156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
    Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
    Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence and harm of nonalcoholic fatty liver disease].
    Shao YL; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):10-13. PubMed ID: 30685917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
    World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Lonardo A
    Adv Ther; 2017 Jun; 34(6):1291-1326. PubMed ID: 28526997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us?
    Aggarwal A; Puri K; Thangada S; Zein N; Alkhouri N
    Curr Pediatr Rev; 2014; 10(2):151-61. PubMed ID: 25088269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
    Satapathy SK; Sanyal AJ
    Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).
    Golabi P; Otgonsuren M; de Avila L; Sayiner M; Rafiq N; Younossi ZM
    Medicine (Baltimore); 2018 Mar; 97(13):e0214. PubMed ID: 29595666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease and statins.
    Tziomalos K; Athyros VG; Paschos P; Karagiannis A
    Metabolism; 2015 Oct; 64(10):1215-23. PubMed ID: 26234727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic Fatty Liver Disease and Liver Transplantation.
    Pham T; Dick TB; Charlton MR
    Clin Liver Dis; 2016 May; 20(2):403-17. PubMed ID: 27063277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obese children with fatty liver: Between reality and disease mongering.
    Ranucci G; Spagnuolo MI; Iorio R
    World J Gastroenterol; 2017 Dec; 23(47):8277-8282. PubMed ID: 29307987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.
    Chacko KR; Reinus J
    Clin Liver Dis; 2016 May; 20(2):387-401. PubMed ID: 27063276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population.
    Meng G; Zhang B; Yu F; Li C; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Shi H; Su Q; Gu Y; Fang L; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Jiao H; Wang B; Guo Q; Carvalhoa LA; Sun Z; Song K; Yu M; Niu K
    Eur J Nutr; 2018 Sep; 57(6):2113-2121. PubMed ID: 28702720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
    Gehrke N; Schattenberg JM
    Gastroenterology; 2020 May; 158(7):1929-1947.e6. PubMed ID: 32068022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.
    Rosato V; Masarone M; Dallio M; Federico A; Aglitti A; Persico M
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31540048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
    Sayiner M; Koenig A; Henry L; Younossi ZM
    Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.